Concepedia

Adam E. Mullick

AE

Statistics

Publications

61

Citations

5.3K

H-Index

33

Active since

1999

Affiliations

Ionis Pharmaceuticals (United States)(Current)

University of Kentucky

University of California, Davis

New York University

University of California San Diego

Adam E. Mullick is an author at Ionis Pharmaceuticals (United States) specializing in life sciences, pharmacology, and medicine.

ORCID

Publications per year

1999–2025

61

Publications

61

CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation

Frederick J. Sheedy, Alena Grebe, Katey J. Rayner et al. · Nature Immunology · 2013 · 906 citations · Full text

, , +13

Modulation of atherosclerosis in mice by Toll-like receptor 2

Adam E. Mullick · Journal of Clinical Investigation · 2005 · 549 citations · Full text

, , +16

Antisense Oligonucleotide Inhibition of Apolipoprotein C-III Reduces Plasma Triglycerides in Rodents, Nonhuman Primates, and Humans

Mark J. Graham, Richard Lee, Thomas A. Bell et al. · Circulation Research · 2013 · 372 citations · Full text

, , +14

ApoC-III inhibits clearance of triglyceride-rich lipoproteins through LDL family receptors

Philip L.S.M. Gordts, Ryan Nock, Ni-Huiping Son et al. · Journal of Clinical Investigation · 2016 · 260 citations · Full text

, , +17

Endothelial cell CD36 optimizes tissue fatty acid uptake

Ni-Huiping Son, Debapriya Basu, Dmitri Samovski et al. · Journal of Clinical Investigation · 2018 · 256 citations · Full text

, , +17

1–5 of 61